Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. - Wikidata - awgldk - TriplyDB

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.

http://www.wikidata.org/entity/Q36965292

about

Avosentan reduces albumin excretion in diabetics with macroalbuminuria Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease Endothelin Blockade in Diabetic Kidney Disease Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat Early life stress sensitizes rats to angiotensin II-induced hypertension and vascular inflammation in adult life.Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.Endothelin B receptor, a new target in cancer immune therapy.Endothelin receptor A antagonism attenuates renal medullary blood flow impairment in endotoxemic pigs.Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.Diabetic nephropathy - complications and treatment.Endothelin and endothelin antagonists in chronic kidney disease.Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats.Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.Endothelin and the podocyte ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats.Tempol prevents altered K(+) channel regulation of afferent arteriolar tone in diabetic rat kidney Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb.Early life stress induces renal dysfunction in adult male rats but not female rats.Sildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.Endothelin-1 and the kidney--beyond BP.Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo.Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis.Novel drugs and intervention strategies for the treatment of chronic kidney disease.Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes PP2B-dependent NO production in the medullary thick ascending limb during diabetes.The importance of endothelin-1 for microvascular dysfunction in diabetes Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials.Molecular interactions of serotonin (5-HT) and endothelin-1 in vascular smooth muscle cells: in vitro and ex vivo analyses.Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis

P2860

Q24642372-05E165D7-38A9-46B5-A614-C3D558F8A07C Q26752292-F6B30135-DC50-4DCC-BEE2-50A7E8FCF0D0 Q26799476-60117362-10B4-4C95-8944-2728BC0CED21 Q27007027-13AEFE77-8E0F-45A7-B37F-5C7D3EF4DF38 Q28575856-EA3519D8-2398-4A85-971E-B9987E02309F Q33690912-962993DE-69DE-44E1-8B1E-EF1C9CFC23FA Q33840559-0FCD4146-3280-40E5-A5FD-BA3FCB127974 Q33960710-1B2516FF-66F6-465F-9DF7-7DAFC1414EFB Q33961467-E0F6FA93-21EC-4FCF-9D2C-29A16615717A Q34360718-C9F73942-9A2F-4968-A1F3-777399D05C04 Q34387952-787F8461-2238-43F9-A5BC-A0239CA94BC5 Q34437692-DF247FFD-A7D7-4502-BC4E-7966689C1572 Q34630324-E444056D-71E9-482F-B777-CD54C44C5ED8 Q34720402-32E0CF9C-746D-4441-9EE6-50EFF7E9556E Q34726905-B7AB4097-3A78-4C8A-BF20-3D66B9E0C82C Q35077906-F137AB4E-9B35-4AA1-9A3B-5B82B0BF9EC6 Q35452282-3DF09D22-D461-4540-A199-37250505DE0F Q35647856-7FD172F7-A405-44BE-816C-B96A1B245856 Q35821566-B8F2D28C-21D3-474E-92AE-9F2BEB7B73A9 Q35920538-BD3E482D-F507-457F-8EA0-FEA857E13BA4 Q35924532-94E959A9-3D67-434C-B56E-93352C8F3029 Q36100815-1A9B83A8-CF90-4070-B575-3278CA83E97E Q36528013-04BC17BF-448E-4389-82FB-CEC9090B6D29 Q36576619-73BC5834-3D4F-462A-BF16-4ECFF3E024B6 Q36619734-E6242069-EBC7-4AA3-91E9-515C6EFCE371 Q36807062-AE9BE606-4C18-4115-ADD8-98B690C7D3DD Q36844501-653C31AE-FE4D-4A91-BD5F-5E902AC906B8 Q37084544-923127E4-6821-4CDF-A511-4C98B4355E9B Q37129456-CC3F638B-3862-490B-8F78-5139429D7585 Q37216920-3A6EF1AF-F8B8-452E-B77D-32018545391B Q37219043-0356553A-1512-4974-B0D7-6C3C1F688738 Q37219055-5E4B6539-EE23-4FB0-A594-63259B83B980 Q37233045-9DD5CC76-2809-4F1E-B825-D3AC4DE55B71 Q37244688-90EFB8F6-8E50-4B93-914B-B1392C2E66E1 Q37298520-F64F05A3-5134-4019-98D5-0435F3EE34C9 Q37381938-1EAE44A4-CBC4-44F7-ACE7-E0D381E763E4 Q37573815-47AC2AE9-125D-4A38-A909-5B83AF89706B Q37575289-644FAF45-A184-4213-AA8E-2273266014CC Q37597721-2D42F471-71FA-4A08-9630-C84A72133E77 Q37733555-117C8077-B24D-4679-B1DB-9F1FB05584A9

P2860

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.

http://www.wikidata.org/entity/Q36965292

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Endothelin A receptor blockade ...... n anti-inflammatory mechanism.

@en

type

label

Endothelin A receptor blockade ...... n anti-inflammatory mechanism.

@en

prefLabel

Endothelin A receptor blockade ...... n anti-inflammatory mechanism.

@en

P1433

Q36965292-E5BA5606-4C9A-40DB-8065-22B781F35BA1

P1476

Q36965292-D97FFDB5-24C5-44F3-9F7C-C20BEA40AC2D

P2093

Q36965292-39AEC0AB-FE88-4DFA-ABD0-E683563D96BC

Q36965292-64F1F7D7-AE55-4545-8A9F-926FD7B7AA8C

Q36965292-6C4EA067-73EA-40CD-B69D-B8729E62F11D

Q36965292-B3C32EFC-CBED-47AD-9F11-8C317E09C928

Q36965292-E26A739B-F9CC-405E-8E24-EA2614699EC4

Q36965292-E4B54BFC-229E-4F62-916C-0CC63235429E

P2860

Q36965292-0DC44AF6-9975-4EB7-8A94-ED5585085EEE

Q36965292-17D62CA6-C85B-477E-9134-285C50288F85

Q36965292-1A198670-8DE4-4707-B98B-7B9AFFBC6384

Q36965292-1CF404C4-BCF6-4025-A205-75D485FF1B36

Q36965292-2B5C9C12-CC4A-425D-8843-FE93D9DB0BD7

Q36965292-2E5B6C14-1844-412B-BFAC-38452A6BCA9E

Q36965292-36B96E83-3C73-4DDE-A60E-0D0522FBFDD7

Q36965292-3BD43C18-E800-481A-847C-C6CCE7AB3185

Q36965292-3C2EFE52-0D76-4A72-9DF1-6078047A246E

Q36965292-4911C866-1732-4DB3-9FD0-88FE71ACA269

P304

Q36965292-6E008571-0666-424A-8113-972A79EA1A98

P31

Q36965292-5F1F428A-0CFD-42AE-B295-8D0E0E985B8E

P356

Q36965292-E87EA0E8-7C7C-4052-88C4-879AC802A7F4

P433

Q36965292-9EF1F102-1D04-434C-9D99-E4BAD2F84328

P478

Q36965292-264A804C-9745-436A-96DC-7F9C4FBD7773

P50

Q36965292-5ED91D09-C893-4E0A-AB12-01A5880F95EA

P577

Q36965292-39BEB742-7320-4103-8749-BB7D9FD61E9B

P5875

Q36965292-8C547EE7-3942-49D4-9D92-C1A31306B4CD

P698

Q36965292-32A990E6-E42A-40ED-B518-88D9239A9934

P921

Q36965292-4E2E2E55-315B-4C39-B0B6-4B6960224EF0

P932

Q36965292-3DDCF7C0-C6A3-41AF-9422-A5A9CC089868

P356

P1433

Journal of the American Society of Nephrology

P1476

Endothelin A receptor blockade ...... n anti-inflammatory mechanism.

@en

P2093

David M Pollock

http://www.w3.org/2001/XMLSchema#string

Janet L Hobbs

http://www.w3.org/2001/XMLSchema#string

Jennifer C Sullivan

http://www.w3.org/2001/XMLSchema#string

Jennifer S Pollock

http://www.w3.org/2001/XMLSchema#string

Pamela K Carmines

http://www.w3.org/2001/XMLSchema#string

Tatsuo Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist

The pathobiology of diabetic complications: a unifying mechanism

Leukocyte recruitment and vascular injury in diabetic nephropathy.

Indices of lipid peroxidation in vivo: strengths and limitations.

Estimated rate of thromboxane secretion into the circulation of normal humans

Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1

Physiology and pathology of endothelin-1 in renal mesangium.

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.

Nitric oxide, oxidative stress, and progression of chronic renal failure.

Transforming growth factor beta contributes to progressive diabetic nephropathy

P304

143-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2006030208

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer M. Sasser

P577

2006-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6633125

http://www.w3.org/2001/XMLSchema#string

P698

17167119

http://www.w3.org/2001/XMLSchema#string

P921

P932

2579758

http://www.w3.org/2001/XMLSchema#string